Abstract
AbstractAs COVID-19 vaccines became widely available worldwide, many countries implemented vaccination certification, also known as a “green pass”, to promote and expedite vaccination on containing virus spread from the latter half of 2021. This policy allowed those vaccinated to have more freedom in public activities compared to more constraints on the unvaccinated in addition to existing non-pharmaceutical interventions (NPIs). Accordingly, the vaccination certification also induced heterogeneous behaviors of unvaccinated and vaccinated groups. This makes it essential yet challenging to model the behavioral impact of vaccination certification on the two groups and the transmission dynamics of COVID-19 within and between the groups. Very limited quantitative work is available for addressing these purposes. Here we propose an extended epidemiological model SEIQRD$$^2$$
2
to effectively distinguish the behavioral impact of vaccination certification on unvaccinated and vaccinated groups through incorporating two contrastive transmission chains. SEIQRD$$^2$$
2
also quantifies the impact of the green pass policy. With the resurgence of COVID-19 in Greece, Austria, and Israel in 2021, our simulation results indicate that their implementation of vaccination certification brought about more than a 14-fold decrease in the total number of infections and deaths as compared to a scenario with no such a policy. Additionally, a green pass policy may offer a reasonable practical solution to strike the balance between public health and individual’s freedom during the pandemic.
Funder
Australian Research Council Discovery
Australian Research Council Future Fellowship
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Chow, E. J., Uyeki, T. M. & Chu, H. Y. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat. Rev. Microbiol. 21, 195–210 (2023).
2. Aruffo, E. et al. Mathematical modelling of vaccination rollout and NPIS lifting on COVID-19 transmission with VOC: A case study in toronto, canada. BMC Public Health 22, 1–12 (2022).
3. Ritchie, H. et al. Our world in data. Coronavirus (COVID-19) vaccinations. Accessed March 16th, 2021 (2021).
4. Gavish, N., Yaari, R., Huppert, A. & Katriel, G. Population-level implications of the israeli booster campaign to curtail COVID-19 resurgence. Sci. Transl. Med. 14, eabn9836 (2022).
5. Cao, L. & Liu, Q. COVID-19 modeling: A review. medRxiv 2022-08 (2022).